86 related articles for article (PubMed ID: 25543836)
1. Proteomic studies of pediatric medulloblastoma tumors with 17p deletion.
Anagnostopoulos AK; Papathanassiou C; Karamolegou K; Anastasiadou E; Dimas KS; Kontos H; Koutsopoulos A; Prodromou N; Tzortzatou-Stathopoulou F; Tsangaris GT
J Proteome Res; 2015 Feb; 14(2):1076-88. PubMed ID: 25543836
[TBL] [Abstract][Full Text] [Related]
2. Molecular Proteomic Characterization of a Pediatric Medulloblastoma Xenograft.
Tsangaris GT; Dimas K; Malamou A; Katsafadou A; Papathanasiou C; Stravopodis DJ; Vorgias CE; Gazouli M; Anagnostopoulos AK
Cancer Genomics Proteomics; 2017; 14(4):267-275. PubMed ID: 28647700
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors.
Biegel JA; Burk CD; Barr FG; Emanuel BS
Cancer Res; 1992 Jun; 52(12):3391-5. PubMed ID: 1596898
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
[TBL] [Abstract][Full Text] [Related]
5. Correlation of chromosome 17p loss with clinical outcome in medulloblastoma.
Emadian SM; McDonald JD; Gerken SC; Fults D
Clin Cancer Res; 1996 Sep; 2(9):1559-64. PubMed ID: 9816333
[TBL] [Abstract][Full Text] [Related]
6. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.
Bayani J; Zielenska M; Marrano P; Kwan Ng Y; Taylor MD; Jay V; Rutka JT; Squire JA
J Neurosurg; 2000 Sep; 93(3):437-48. PubMed ID: 10969942
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors.
Thomas GA; Raffel C
Cancer Res; 1991 Jan; 51(2):639-43. PubMed ID: 1670763
[TBL] [Abstract][Full Text] [Related]
8. Deletion mapping of the medulloblastoma locus on chromosome 17p.
Cogen PH; Daneshvar L; Metzger AK; Edwards MS
Genomics; 1990 Oct; 8(2):279-85. PubMed ID: 1979050
[TBL] [Abstract][Full Text] [Related]
9. Integrated proteomic platforms for the comparative characterization of medulloblastoma and pilocytic astrocytoma pediatric brain tumors: a preliminary study.
Martelli C; Iavarone F; D'Angelo L; Arba M; Vincenzoni F; Inserra I; Delfino D; Rossetti DV; Caretto M; Massimi L; Tamburrini G; Di Rocco C; Caldarelli M; Messana I; Castagnola M; Sanna MT; Desiderio C
Mol Biosyst; 2015 Jun; 11(6):1668-83. PubMed ID: 25909245
[TBL] [Abstract][Full Text] [Related]
10. Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood.
Raffel C; Gilles FE; Weinberg KI
Cancer Res; 1990 Feb; 50(3):587-91. PubMed ID: 1967549
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.
von Haken MS; White EC; Daneshvar-Shyesther L; Sih S; Choi E; Kalra R; Cogen PH
Genes Chromosomes Cancer; 1996 Sep; 17(1):37-44. PubMed ID: 8889505
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 17p deletion in human medulloblastoma: a missing checkpoint in the Hedgehog pathway.
De Smaele E; Di Marcotullio L; Ferretti E; Screpanti I; Alesse E; Gulino A
Cell Cycle; 2004 Oct; 3(10):1263-6. PubMed ID: 15467454
[TBL] [Abstract][Full Text] [Related]
13. No preferential parent of origin for the isochromosome 17q in childhood primitive neuroectodermal tumor (medulloblastoma).
Biegel JA; Wentz E
Genes Chromosomes Cancer; 1997 Feb; 18(2):143-6. PubMed ID: 9115964
[TBL] [Abstract][Full Text] [Related]
14. Genomic deletions in cell lines derived from primitive neuroectodermal tumors of the central nervous system.
Dallas PB; Terry PA; Kees UR
Cancer Genet Cytogenet; 2005 Jun; 159(2):105-13. PubMed ID: 15899381
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic studies in medulloblastomas: evidence for tumor suppressor genes at the chromosomal regions 1q31-32 and 17p13.
Pietsch T; Koch A; Wiestler OD
Klin Padiatr; 1997; 209(4):150-5. PubMed ID: 9293446
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic evaluation of isochromosome 17q in posterior fossa tumors of children and correlation with clinical outcome in medulloblastoma. Detection of a novel chromosomal abnormality.
DeChiara C; Borghese A; Fiorillo A; Genesio R; Conti A; D'Amore R; Pettinato G; Varone A; Maggi G
Childs Nerv Syst; 2002 Aug; 18(8):380-4. PubMed ID: 12192498
[TBL] [Abstract][Full Text] [Related]
17. Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma.
McDonald JD; Daneshvar L; Willert JR; Matsumura K; Waldman F; Cogen PH
Genomics; 1994 Sep; 23(1):229-32. PubMed ID: 7829075
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma.
Rood BR; Zhang H; Weitman DM; Cogen PH
Cancer Res; 2002 Jul; 62(13):3794-7. PubMed ID: 12097291
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia.
Müller HL; Oh Y; Lehrnbecher T; Blum WF; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Aug; 79(2):428-34. PubMed ID: 7519190
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
